20180531
- Categories:企业里程碑
- Author:
- Origin:
- Time of issue:2018-05-31
- Views:0
(Summary description)On May 31, 2018, the approval for clinical trial of recombinant bivalent HPV-6/11 vaccine (Hansenula polymorpha) was obtained.
20180531
(Summary description)On May 31, 2018, the approval for clinical trial of recombinant bivalent HPV-6/11 vaccine (Hansenula polymorpha) was obtained.
- Categories:企业里程碑
- Author:
- Origin:
- Time of issue:2018-05-31
- Views:0
On May 31, 2018, the approval for clinical trial of recombinant bivalent HPV-6/11 vaccine (Hansenula polymorpha) was obtained.
Scan the QR code to read on your phone
- TOP
Contact Us
底部联系方式
Jiangsu Recbio Technology Co., Ltd.
Media Inquiry: media@recbio.cn
Investor Inquiry: ir@recbio.cn
Address: Vaccine Engineering Center, China Medical City, Taizhou
Copyright © 2020 Jiangsu Rec-Biotechnology Co., Ltd. All rights reserved. 苏ICP备19043567号-1
